Literature DB >> 18926330

Lamin A/C gene and the heart: how genetics may impact clinical care.

Luisa Mestroni, Matthew R G Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18926330      PMCID： PMC2571955          DOI： 10.1016/j.jacc.2008.07.021

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

Review 1.  Human laminopathies: nuclei gone genetically awry.

Authors:  Brian C Capell; Francis S Collins
Journal:  Nat Rev Genet       Date:  2006-12       Impact factor: 53.242

2.  Primary prevention of sudden death in patients with lamin A/C gene mutations.

Authors:  Christophe Meune; Jop H Van Berlo; Frédéric Anselme; Gisèle Bonne; Yigal M Pinto; Denis Duboc
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

3.  Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy.

Authors:  S Kärkkäinen; E Reissell; T Heliö; M Kaartinen; P Tuomainen; L Toivonen; J Kuusisto; M Kupari; M S Nieminen; M Laakso; K Peuhkurinen
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

4.  High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation.

Authors:  H M Bécane; G Bonne; S Varnous; A Muchir; V Ortega; E H Hammouda; J A Urtizberea; T Lavergne; M Fardeau; B Eymard; S Weber; K Schwartz; D Duboc
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

Review 5.  The laminopathies: a clinical review.

Authors:  J Rankin; S Ellard
Journal:  Clin Genet       Date:  2006-10       Impact factor: 4.438

6.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

7.  Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.

Authors:  Eloisa Arbustini; Andrea Pilotto; Alessandra Repetto; Maurizia Grasso; Andrea Negri; Marta Diegoli; Carlo Campana; Laura Scelsi; Elisa Baldini; Antonello Gavazzi; Luigi Tavazzi
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

8.  Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.

Authors:  Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Amanda Peterson; Duanxiang Li; Petra Jakobs; Michael Litt; Charles B Porter; Peter S Rahko; Ray E Hershberger
Journal:  Am Heart J       Date:  2008-03-12       Impact factor: 4.749

9.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

Authors:  J Peter van Tintelen; Robert M W Hofstra; Hilga Katerberg; Tom Rossenbacker; Ans C P Wiesfeld; Gideon J du Marchie Sarvaas; Arthur A M Wilde; Irene M van Langen; Eline A Nannenberg; Anneke J van der Kooi; Marian Kraak; Isabelle C van Gelder; Dirk Jan van Veldhuisen; Yvonne Vos; Maarten P van den Berg
Journal:  Am Heart J       Date:  2007-09-14       Impact factor: 4.749

10.  Long-term outcome and risk stratification in dilated cardiolaminopathies.

Authors:  Michele Pasotti; Catherine Klersy; Andrea Pilotto; Nicola Marziliano; Claudio Rapezzi; Alessandra Serio; Savina Mannarino; Fabiana Gambarin; Valentina Favalli; Maurizia Grasso; Manuela Agozzino; Carlo Campana; Antonello Gavazzi; Oreste Febo; Massimiliano Marini; Maurizio Landolina; Andrea Mortara; Giovanni Piccolo; Mario Viganò; Luigi Tavazzi; Eloisa Arbustini
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094
View more
  13 in total

Review 1.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 2.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

Review 3.  Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies.

Authors:  Xi Wang; Allyson Zabell; Wonshill Koh; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

4.  Skin deep: what can the study of dermal fibroblasts teach us about dilated cardiomyopathy?

Authors:  Brian C Jensen
Journal:  J Mol Cell Cardiol       Date:  2009-12-11       Impact factor: 5.000

5.  A novel LMNA mutation (R189W) in familial dilated cardiomyopathy: evidence for a 'hot spot' region at exon 3: a case report.

Authors:  Nicoletta Botto; Simona Vittorini; Maria Giovanna Colombo; Andrea Biagini; Umberto Paradossi; Giovanni Aquaro; Maria Grazia Andreassi
Journal:  Cardiovasc Ultrasound       Date:  2010-03-22       Impact factor: 2.062

6.  LMNA E82K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice.

Authors:  Dan Lu; Hong Lian; Xiaojuan Zhang; Haitao Shao; Lan Huang; Chuan Qin; Lianfeng Zhang
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

7.  Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy.

Authors:  Jessica R Golbus; Megan J Puckelwartz; Lisa Dellefave-Castillo; John P Fahrenbach; Viswateja Nelakuditi; Lorenzo L Pesce; Peter Pytel; Elizabeth M McNally
Journal:  Circ Cardiovasc Genet       Date:  2014-09-01

8.  Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.

Authors:  L Subramanyam; V Simha; A Garg
Journal:  Clin Genet       Date:  2009-12-22       Impact factor: 4.438

9.  Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy.

Authors:  Marko Sysi-Aho; Juha Koikkalainen; Tuulikki Seppänen-Laakso; Maija Kaartinen; Johanna Kuusisto; Keijo Peuhkurinen; Satu Kärkkäinen; Margareta Antila; Kirsi Lauerma; Eeva Reissell; Raija Jurkko; Jyrki Lötjönen; Tiina Heliö; Matej Orešič
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

Review 10.  Dilated cardiomyopathy produced by lamin A/C gene mutations.

Authors:  Cerasela Mihaela Goidescu
Journal:  Clujul Med       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.